Aquinox Pharmaceuticals Announces First Quarter 2016 Financial Results
10 mai 2016 09h05 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, May 10, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Presentation of LEADERSHIP 201 Results at Upcoming American Urological Association Annual Meeting
05 mai 2016 09h15 HE
|
Neoleukin Therapeutics, Inc.
Phase II Results Accepted for Publication in Journal of Urology VANCOUVER, British Columbia, May 05, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a...
Aquinox to Present at 2016 Bloom Burton & Co. Healthcare Investor Conference
28 avr. 2016 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, April 28, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox to Present at 2016 Annual Needham Healthcare Conference
06 avr. 2016 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, April 06, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Year End 2015 Financial Results
14 mars 2016 16h00 HE
|
Neoleukin Therapeutics, Inc.
Advancing to first Phase 3 trial for AQX-1125 in IC/BPSHost conference call update today at 4:30PM ET VANCOUVER, British Columbia, March 14, 2016 (GLOBE NEWSWIRE) -- Aquinox...
Aquinox Pharmaceuticals Announces Year End 2015 Financial Results
08 mars 2016 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, March 08, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox to Present at LEERINK Partners 5th Annual Global Healthcare Conference
28 janv. 2016 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Jan. 28, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Announces Update on Development Program for AQX-1125 Following Meeting With FDA
11 janv. 2016 07h00 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Appointment of Ms. Shelley McCloskey as Vice President, Human Resources & Administration
22 déc. 2015 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Dec. 22, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Selected for Addition to NASDAQ Biotechnology Index
16 déc. 2015 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Dec. 16, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...